---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-044012"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:11:37.148984+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Evofem restructures convertible notes; changes governing law, reissues under Section 3(a)(9)

## Summary
- Modified eight series of senior convertible notes issued Dec 2022–Sep 2023; no new consideration paid.
- Changed governing law from New York to Delaware; notes reissued under Securities Act Section 3(a)(9) exemption.
- Conversion price set at $0.0635 per share; default interest rate 12%; beneficial ownership cap 4.99%.

## SEC filing metadata
- accession: 0001493152-23-044012
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000149315223044012/0001493152-23-044012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000149315223044012/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-044012
- JSON: https://secwatch.observer/filing/0001493152-23-044012.json
- Plain text: https://secwatch.observer/filing/0001493152-23-044012.txt

## Key facts
- Material Agreements
  Evofem Biosciences, Inc. amended Restructuring Agreements with certain holders of the Company's previously issued securities (effective 2023-12-01).
  - Action: amendment
  - Agreement: notes offering
  - Counterparty: certain holders of the Company's previously issued securities
  - Effective: 2023-12-01
  source text: On December 1, 2023, Evofem Biosciences, Inc. (the “Company”) entered into agreements with the holders (each a “Holder”) of certain of the Company’s previously issued securities (collectively, the “Restructuring Agreements”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618835/000149315223044012/0001493152-23-044012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.